Financhill
Buy
74

CNTX Quote, Financials, Valuation and Earnings

Last price:
$2.46
Seasonality move :
-0.89%
Day range:
$2.12 - $2.45
52-week range:
$0.49 - $2.45
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
3.08x
Volume:
4M
Avg. volume:
1.8M
1-year change:
182.35%
Market cap:
$225.6M
Revenue:
--
EPS (TTM):
-$0.28

Earnings Data

Next earnings date for CNTX
--
Most recent earnings per share
-$0.10
Missed by $0.01
(Nov 6/2025)
Consensus Estimate
-$0.09
(Nov 6/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

CNTX Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/31/2026 Q1 -- -- -- -$0.11 --
12/31/2025 Q4 -- -- -- -$0.10 --
11/06/2025 Q3 -- -- -$0.10 -$0.09 -$0.01
08/06/2025 Q2 -- -- -$0.09 -$0.05 -$0.04
05/07/2025 Q1 -- -- -$0.05 -$0.06 $0.02
03/20/2025 Q4 -- -- -$0.04 -$0.09 $0.05
11/06/2024 Q3 -- -- -$0.22 -$0.09 -$0.13
08/07/2024 Q2 -- -- -$0.04 -$0.07 $0.03
03/31/2024 Q1 -- -- -$0.23 -$0.44 $0.21
12/31/2023 Q4 -- -- -$0.42 -$0.35 -$0.07
09/30/2023 Q3 -- -- -$0.37 -$0.31 -$0.06
08/11/2023 Q2 -- -- -$0.31 -- --
05/11/2023 Q1 -- -- -$0.40 -- --
03/23/2023 Q4 -- -- -$0.22 -- --
12/02/2022 Q3 -- -- -$0.24 -- --
08/11/2022 Q2 -- -- -$0.25 -- --
05/11/2022 Q1 -- -- -$0.22 -- --
12/31/2021 Q4 -- -- -$0.19 -- --
12/02/2021 Q3 -- -- -$0.13 -- --
06/30/2021 Q2 -- -- -$0.46 -- --
03/31/2021 Q1 -- -- -$0.08 -- --
12/31/2020 Q4 -- -- -$0.03 -- --
09/30/2020 Q3 -- -- -$0.08 -- --
06/30/2020 Q2 -- -- $0.68 -- --
03/31/2020 Q1 -- -- $0.08 -- --

Context Therapeutics, Inc. Earnings Questions

  • How Much did Context Therapeutics, Inc. Generate in Revenue Last Quarter?

    Context Therapeutics, Inc. reported -- worth of top line sales in its most recent quarter.

  • Did Context Therapeutics, Inc. Beat Earnings Last Quarter?

    Context Therapeutics, Inc. announced earnings per share of -$0.10 which represents a miss of analyst forecast a -$0.09 per share.

  • Is Context Therapeutics, Inc. Profitable?

    Context Therapeutics, Inc. reported -$4.1K that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Context Therapeutics, Inc. EPS Next Year?

    Context Therapeutics, Inc.'s earnings are forecast to decrease from -$0.46 per share to -$0.35 per share next year representing a decrease of -23.5%.

  • When is Context Therapeutics, Inc.'s Earnings Date?

    Currently, Context Therapeutics, Inc. has not yet stated when its earnings date is, however, based on past estimates it's likely to take place on May 1, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

How Big Will the SpaceX IPO Be?
How Big Will the SpaceX IPO Be?

Operated up to now as a private business, SpaceX will…

Where Will ISRG Stock Be in 5 Years?
Where Will ISRG Stock Be in 5 Years?

Intuitive Surgical (NASDAQ:ISRG) is the innovative medical tech business behind…

Is Kratos Stock a Good Investment?
Is Kratos Stock a Good Investment?

UAV and hypersonic system defense contractor Kratos (NASDAQ:KTOS) has swung…

Stock Ideas

Buy
59
Is NVDA Stock a Buy?

Market Cap: $4.7T
P/E Ratio: 65x

Buy
59
Is GOOG Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 42x

Sell
48
Is GOOGL Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 42x

Alerts

Buy
72
BNAI alert for Jan 29

Brand Engagement Network, Inc. [BNAI] is down 16.89% over the past day.

Buy
82
STX alert for Jan 29

Seagate Technology Holdings Plc [STX] is up 0.83% over the past day.

Buy
84
GDXU alert for Jan 29

MicroSectors Gold Miners 3X Leveraged ETN [GDXU] is down 12.19% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock